Effects of aspirin and omega-3 fatty acids on composite and subdomain scores from the NEI-VFQ-25 questionnaire: the ASCEND-Eye randomized controlled trial

Effects of aspirin and omega-3 fatty acids on composite and subdomain scores from the NEI-VFQ-25 questionnaire: the ASCEND-Eye randomized controlled trial

Abstract Background The double-blind, 2 × 2 factorial design, placebo-controlled ASCEND randomized trial compared the effects of 100 mg aspirin daily and, separately, 1 g omega-3 fatty acids (FAs) daily on the primary prevention of cardiovascular disease in 15,480 UK adults with diabetes. We report...

Full description

Bibliographic Details
Main Authors: Emily L. Sammons, Georgina Buck, Louise J. Bowman, William M. Stevens, Imen Hammami, Sarah Parish, Jane Armitage, on behalf of the ASCEND Study Collaborative Group
Format: Article
Language:English
Published: BMC 2024-11-01
Series:BMC Ophthalmology
Subjects:
Aspirin
Omega-3 fatty acids
NEI-VFQ-25
Randomized controlled trial
Diabetes
Online Access:https://doi.org/10.1186/s12886-024-03741-x

Internet

https://doi.org/10.1186/s12886-024-03741-x

Similar Items